期刊文献+

酮康唑水分散软颗粒的制备及稳定性考察 被引量:1

Preparation and stability of ketoconazole water dispersible soft granules
下载PDF
导出
摘要 目的:研究酮康唑水分散软颗粒的制备及质量检测方法,并考察其稳定性。方法:采用熔融法制备酮康唑水分散软颗粒,用红外光谱法、扫描电镜法和X射线衍射法对其进行物相鉴别,用紫外分光光度法测定含量,最后考察其加速稳定性。结果:物相鉴别表明,酮康唑水分散软颗粒中酮康唑与辅料之间形成了类似于固体分散体之间的作用力,而非简单的物理混合;加速和长期稳定性试验表明,酮康唑水分散软颗粒中酮康唑含量基本无变化。结论:采用熔融法制粒,制得的酮康唑水分散软颗粒的稳定性较好,符合水分散软颗粒的质量要求。 Objective:To develop ketoconazole water dispersible soft granules and study the stability. Methods:Ketoconazole water dispersible soft granules were prepared by fusion method. Infrared spectrophotometery, scanning electronical microscope, X-ray diffraction and ultra-violet spectrophotometry were used for characterizations. The accelerated stability was investigated. Results:Ketoconazole water dispersible soft granules were not a simple physical mixture but the solid dispersion-like complexes in which there were interaction between ketoconazole and excipients. Results of the stability showed that the main active content was not changed significantly under the experimental conditions. Conclusions:The fusion method is suitable for preparation of ketoconazole water dispersible soft granules. The stability and measurements meet the Chinese Pharmacopoeia 2005 edition (Part I).
出处 《中国新药杂志》 CAS CSCD 北大核心 2007年第16期1283-1286,共4页 Chinese Journal of New Drugs
关键词 酮康唑 水分散软颗粒 质量检测 稳定性 ketoconazole water dispersible soft granules quality control stability
  • 相关文献

参考文献6

  • 1FORD JL,RUBINSTEIN MH.Formulation and aging of tablets prepared from indomethacin poly(ethylene glycol)6000 solid dispersions[J].Pharm Acta Helv,1980,55(1):1 -7.
  • 2SJ(O)KVIST E,NYSTR(O)M C.Physicochemical aspects of drug release XI.Tableting properties of solid dispersion using xylitol as carrier material[J].Int J Pharm,1991,67(1):139-153.
  • 3盛春泉,季海涛,张万年.氮唑类抗真菌药物研究新进展[J].中国新药杂志,2002,11(4):278-281. 被引量:11
  • 4AOYAMA Y,YOSHIDA Y,SONODA Y,et al.Role of the side chain of lanosterolin substrate recognition and catalytic activity of lanosterol 14α demethylase (cytochrome P45014DM) of yeast[J].Biochim Biophys Acta,1991,1081 (3):262 -266.
  • 5赵巧玲,高永良.固体分散体的释药机制及其稳定性的研究进展[J].国外医学(药学分册),2005,32(1):52-56. 被引量:19
  • 6罗延红.一种新型农药水分散粒剂的研制[D].杨凌:西北农林科技大学,2004:55-56.

二级参考文献20

  • 1Verreck G, Chun I,Peeters J, et al. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning [ J ]. Pharm Res,2003,20(5) :810 - 817.
  • 2Dannenfelser RM, He H, Joshi Y, et al. Development of clinical dosage forms for a poorly water soluble drug Ⅰ : application of polyethylene glycol-polysorbate 80 solid dispersioncartier system[J]. J Pharm Sci ,2004,93(5) : 1165 - 1175.
  • 3Serajuddin AT. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs[J]. J Pharm Sci, 1999, 88(10): 1058 -1066.
  • 4Verreck G, Vandecruys R, De Conde V, et al. The use of three different solid dispersion formulations-melt extrusion,film-coated beads, and a glass thermoplastic system-to improve the bioavailability of a nova] microsomal triglyceride transfer protein inhibitor [ J ]. J Pharm Sci, 2004, 93 ( 5 ):1217- 1228.
  • 5Verheyen S, Blaton N, Kinget R, et al. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 sohd dispersions[ J]. Int J Phann,2002, 249(1 - 2) :45 - 58.
  • 6Kushida I, Ichikawa M, Asakawa N. Improvement of dissolution and oral absorption of ER-34122, a poorly water-solubledual 5-hpoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion [J ]. J Pharm Sci ,2002,91(1) :258 - 266.
  • 7Craig DQ. The mechanisms of drug release from solid dispersion in water-soluble polymers[ J]. Int J Pharm, 2002,231(2) : 131 - 144.
  • 8Lloyd GR, Craig DQ, Smith A. A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions[J]. Ear J Pharm Biopharm, 1999, 48(1):59-65.
  • 9Matsumoto T,Zografi G.Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidone)and poly(vinylpyrrohdone-co-vinyl-acetale) in relation to indomethacin crystallization[ J]. Pharm Res, 1999, 16( 11 ):1722- 1728.
  • 10Van den Mooter G,Wuyts M,Blaton N, et al . Physical stabilization of amorphous ketoconazole in sofid dispersions with polyvinylpyrrolidone K25 [ J ]. Eur J Pharm Sci, 2001, 12(3) :261 - 269.

共引文献28

同被引文献3

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部